Search results
HOLLYWOOD, Oct. 31 (UPI) --Henry Daniell, an Englishborn character actor, died apparently of a heart attack today. He was 69 years old. View Full Article in Timesmachine »
Henry Daniell was born on the 5th of March, 1894. He was popular for being a Movie Actor. Remembered for playing villains in numerous films of the 1930s, ’40s, and ’50s, he is perhaps most well known for his roles in The Woman in Green (as Professor Moriarty); Jane Eyre (as Mr. Brocklehurst); and Camille (as the Baron de Varville).
Henry Daniell is Professor and Director of Translational Research at the University of Pennsylvania. He is the Fellow of the American Association for the Advancement of Science and a foreign member of the Italian National Academy of Sciences (14th American to be inducted in the past 240 years) and the Editor in Chief of the Plant Biotechnology Journal, Oxford, UK. He is recipient of several awards including the American Diabetes Association Award, American Heart Association ...
Henry Daniell. Actor. Born March 5, 1894 in London, England, UK. One of Hollywood's greatest screen villains, Charles Henry Pywell Daniell was born in London, England, the son of Elinor Mary (Wookey) and Henry Pyweh Daniell, L.R.C.P. He had the profound misfortune to make his professional theatrical debut on the eve of World War I.
Henry Daniell (1894–1963) was an English actor best known for his villainous roles in Hollywood films. Media in category "Henry Daniell" The following 5 files are in this category, out of 5 total.
Henry Daniell (5 march 1894 - 31 october 1963) was a British actor who played Professor Moriarty in 1945 in the movie The Woman in Green with Basil Rathbone asSherlock Holmes. He also played 2 supporting roles in the Basil Rathbone's sherlockian movies.
Box 1. Technical Biography. Henry Daniell is internationally recognized for his work on chloroplast engineering and plant molecular pharming. Henry's pioneering contributions to science have led over the years to the development of several orally deliverable biopharmaceuticals for the treatment of major metabolic and genetic disorders such as Alzheimer's disease, diabetes, hypertension, haemophilia, retinopathy and more recently COVID-19.
